Novartis (Switzerland): Shares in Issue Update

The Issuer advises that further to the notice below and following confirmation of the correct number of shares for Novartis (Switzerland, constituent), FTSE announces that the Technical notice should have read as follows:

Novartis (Switzerland): Shares in Issue Update
Changes In FTSE Indices

29 July 2008

Following the receipt of updated share information for Novartis (Switzerland, constituent), resulting in a market capitalisation change greater than USD 2bn, FTSE announces the following changes:

INDEX CHANGE EFFECTIVE FROM
START OF TRADING
FTSE All-World Index Novartis (Switzerland, 7103065) will remain in the index with a decreased shares in issue of 2,263,300,000 and an unchanged investability weighting of 100%.
4 August 2008
FTSE Multinationals Novartis will be treated as above. 4 August 2008
FTSE Global 100 Novartis will be treated as above. 4 August 2008
FTSE Global Sector - Pharmaceuticals Novartis will be treated as above. 4 August 2008
FTSE Global Style Index Novartis will be treated as above. 4 August 2008
FTSE Eurotop 100 Novartis will be treated as above. 4 August 2008
FTSE4Good Global Index Novartis will be treated as above. 4 August 2008
FTSE4Good Europe Index Novartis will be treated as above. 4 August 2008
FTSE4Good Europe 50 Index Novartis will be treated as above. 4 August 2008
FTSE4Good Global 100 Index Novartis will be treated as above. 4 August 2008

FREE TRIAL: FTSE Global Equity Index Series emerging markets indices are segmented by Advanced Emerging and Secondary Emerging, and by large, mid, small and aggregate indices, for as granular an analysis as you require. Our emerging markets expertise is further demonstrated by the range of indices we produce in association with high calibre local partners - Xinhua, JSE and TSEC. We are offering a one month free trial of FTSE GEIS, FTSE Xinhua, FTSE JSE and TSEC Taiwan Indices via one of our vendors or directly from FTSE Group. To find out more please visit our website at www.ftse.com/emergingmarkets

For index related enquiries or further information about FTSE please contact:
Client Services in UK: Tel: +44 (0) 20 7866 1810
Client Services in US: Tel: +1 888 747 FTSE (3873) or +1 212 641 6124
Client Services in Asia Pacific: Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811

Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com